1. Define at risk populations for Hepatitis C
  2. Define progression of fibrosis and staging in patients with Hepatitis C
  3. Identify new treatment options for patients with hepatitis C



Session date: 
03/01/2019 - 2:00pm to 3:00pm CST
IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Andrew Aronsohn, MD